MYUNGMOON Pharm co.,Ltd (KRX:017180)
1,655.00
-13.00 (-0.78%)
Last updated: Apr 28, 2025
MYUNGMOON Pharm co.,Ltd Revenue
In the year 2024, MYUNGMOON Pharm co.,Ltd had annual revenue of 186.44B KRW with 9.95% growth. MYUNGMOON Pharm co.,Ltd had revenue of 49.15B in the quarter ending December 31, 2024, with 14.70% growth.
Revenue
186.44B
Revenue Growth
+9.95%
P/S Ratio
0.29
Revenue / Employee
661.15M
Employees
282
Market Cap
53.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 186.44B | 16.88B | 9.95% |
Dec 31, 2023 | 169.57B | 17.43B | 11.46% |
Dec 31, 2022 | 152.13B | 14.38B | 10.43% |
Dec 31, 2021 | 137.76B | 9.91B | 7.75% |
Dec 31, 2020 | 127.85B | -21.49B | -14.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
PharmaResearch | 350.12B |
Peptron | 3.15B |